A Rare Case of Irinotecan-induced Interstitial Pulmonary Disease and Diffuse Alveolar Hemorrhage in a Patient with Pancreatic Cancer

摘要

Irinotecan is a cytotoxic medication used to treat various cancers.?Diffuse alveolar hemorrhage (DAH) and interstitial pulmonary disease?(IPD) are both serious and life-threatening complications, which are rarely reported to be associated with irinotecan. In our case, however, a pancreatic cancer patient developed both DAH and IPD after administration of irinotecan with fluorouracil (5FU).